{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:29:22Z","timestamp":1761863362943,"version":"3.40.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ijcard.2014.11.068","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T20:08:30Z","timestamp":1415304510000},"page":"476-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-7095","authenticated-orcid":false,"given":"Akihide","family":"Konishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Shinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Otake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5775-8072","authenticated-orcid":false,"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Osue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5951-2973","authenticated-orcid":false,"given":"Masamichi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kinutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuroda","family":"Masaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hachidai","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Terashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Shite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-3031","authenticated-orcid":false,"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.11.068_bb0005","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0010","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention","volume":"30","author":"Sibbing","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1253\/circj.CJ-11-0435","article-title":"Impact of platelet reactivity to adenosine diphosphate before implantation of drug-eluting stents on subsequent adverse cardiac events in patients with stable angina","volume":"76","author":"Motoda","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0035","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1253\/circj.CJ-12-0476","article-title":"Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in Japanese patients receiving clopidogrel","volume":"76","author":"Nishio","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1253\/circj.CJ-10-0525","article-title":"Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel","volume":"75","author":"Sawada","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0045","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jcin.2010.07.017","volume":"3","author":"Caixeta","year":"2010","journal-title":"J. Am. Coll. Cardiol. Interv."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0050","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/hrt.2010.204339","article-title":"Optical coherence evaluation of everolimus-eluting stents 8months after implantation","volume":"97","author":"Inoue","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4244\/EIJV6I3A63","article-title":"Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential \u201cthromborestenosis\u201d phenomenon","volume":"6","author":"Oikawa","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","article-title":"Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography","volume":"28","author":"Matsumoto","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcin.2009.03.003","article-title":"Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography","volume":"2","author":"Otake","year":"2009","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","article-title":"Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis","volume":"31","author":"Prati","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.thromres.2006.01.019","article-title":"Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study","volume":"119","author":"Malinin","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0080","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ccd.22267","article-title":"Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis","volume":"75","author":"Nagai","year":"2010","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1163\/156856200743968","article-title":"Surface characterization and platelet adhesion studies on fluorocarbons prepared by plasma-induced graft polymerization","volume":"11","author":"Lin","year":"2000","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0095","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer\u2013drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0100","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2014.11.068_bb0105","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.11.068_bb0110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","article-title":"A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314022104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314022104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T20:49:03Z","timestamp":1717534143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314022104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":22,"alternative-id":["S0167527314022104"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.068","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.11.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}